These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9636423)

  • 1. Comparative effects of malononitriloamide analogs of leflunomide on whole blood lymphocyte stimulation in humans, rhesus macaques, cats, dogs, and rats.
    Gregory CR; Silva HT; Patz JD; Morris RE
    Transplant Proc; 1998 Jun; 30(4):1047-8. PubMed ID: 9636423
    [No Abstract]   [Full Text] [Related]  

  • 2. Malononitrilamides inhibit T- and B-cell responsiveness in different species.
    Kurrle R; Ruuth E; Bartlett R; Lauffer L; Schorlemmer HU
    Transplant Proc; 1997; 29(1-2):1302-3. PubMed ID: 9123316
    [No Abstract]   [Full Text] [Related]  

  • 3. Malononitrilamides inhibit T- and B-cell responsiveness.
    Kurrle R; Bartlett R; Ruuth E; Lauffer L; Schorlemmer HU
    Transplant Proc; 1996 Dec; 28(6):3053-6. PubMed ID: 8962184
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of alloreactivity in the popliteal lymph node assay by malononitrilamides.
    Schorlemmer HU; Bartlett RR; Kurrle R
    Transplant Proc; 1998 Jun; 30(4):968-70. PubMed ID: 9636391
    [No Abstract]   [Full Text] [Related]  

  • 5. Leflunomide (HWA 486) and its analog suppress T- and B-cell proliferation in vitro, acute rejection, ongoing rejection, and antidonor antibody synthesis in mouse, rat, and cynomolgus monkey transplant recipients as well as arterial intimal thickening after balloon catheter injury.
    Morris RE; Huang X; Cao W; Zheng B; Shorthouse RA
    Transplant Proc; 1995 Feb; 27(1):445-7. PubMed ID: 7879056
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperacute skin allograft rejection in presensitized rats is abrogated by malononitrilamides.
    Schorlemmer HU; Kurrle R
    Transplant Proc; 1998 Jun; 30(4):963-7. PubMed ID: 9636390
    [No Abstract]   [Full Text] [Related]  

  • 7. Leflunomide derivative FK778 inhibits production of antibodies in an experimental model of alloreactive T-B cell interaction.
    Ramos-Barrón MA; Gómez-Alamillo C; Santiuste I; Agüeros C; Cosme LS; Benito A; Gimenez T; Merino J; Merino R; Arias M
    Exp Clin Transplant; 2009 Dec; 7(4):218-24. PubMed ID: 20353370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of B cell function by the immunosuppressive agent leflunomide.
    Siemasko KF; Chong AS; Williams JW; Bremer EG; Finnegan A
    Transplantation; 1996 Feb; 61(4):635-42. PubMed ID: 8610393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cyclosporin-resistant B-cell antigen responses by pyrazoles: a tool for the identification of novel molecular mechanisms of B-cell activation.
    Papageorgiou C; Albert R; Andersen E; Zurini M; Hungerford V; Floersheim P; Schreier MH
    Transplant Proc; 2001 May; 33(3):2263-5. PubMed ID: 11377522
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo mechanism of action of leflunomide: selective inhibition of the capacity of B lymphocytes to make T-independent xenoantibodies.
    Lin Y; Waer M
    Transplant Proc; 1996 Dec; 28(6):3085. PubMed ID: 8962194
    [No Abstract]   [Full Text] [Related]  

  • 11. The novel immunosuppressant FK778 inhibits formation of the immunologic Synapse.
    Zeyda M; Geyeregger R; Poglitsch M; Watschinger B; Hörl WH; Stulnig TM; Säemann MD
    Transplant Proc; 2005 May; 37(4):1970-1. PubMed ID: 15919521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leflunomide-mediated tolerance of B lymphocytes for T-independent xenoantigens needs the presence of these xenoantigens.
    Lin Y; Vandeputte M; Waer M
    Transplant Proc; 1997; 29(1-2):1304. PubMed ID: 9123317
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of leflunomide on T-independent xenoantibody formation in rats receiving hamster heart xenografts.
    Lin Y; Vandeputte M; Waer M
    Transplant Proc; 1996 Apr; 28(2):952. PubMed ID: 8623477
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination therapy of malononitrilamide FK778 with tacrolimus on cell proliferation assays and in rats receiving renal allografts.
    Vu MD; Qi S; Wang X; Jiang W; Ma A; Xu D; Bekersky I; Fitzsimmons WE; Wu J; Chen H
    Transplantation; 2003 May; 75(9):1455-9. PubMed ID: 12792496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of leflunomide: in vivo uridine administration reverses its inhibition of lymphocyte proliferation.
    Silva HT; Cao W; Shorthouse R; Morris RE
    Transplant Proc; 1996 Dec; 28(6):3082-4. PubMed ID: 8962193
    [No Abstract]   [Full Text] [Related]  

  • 16. Flow cytometric analysis of the molecular mechanisms of immunosuppressive action of the active metabolite of leflunomide and its malononitrilamide analogues in a novel whole blood assay.
    Slauson SD; Silva HT; Sherwood SW; Morris RE
    Immunol Lett; 1999 Apr; 67(3):179-83. PubMed ID: 10369124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leflunomide, a novel immunomodulatory agent: in vitro analyses of the mechanism of immunosuppression.
    Chong AS; Gebel H; Finnegan A; Petraitis EE; Jiang XL; Sankary HN; Foster P; Williams JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):747-9. PubMed ID: 8438466
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and immunosuppressant activity of pyrazole carboxamides.
    Wang AX; Xie Q; Lane B; Mollison KW; Hsieh GC; Marsh K; Sheets MP; Luly JR; Coghlan MJ
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2787-92. PubMed ID: 9873623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo lymphoproliferation in the popliteal lymph node (PLN) assay can be inhibited by leflunomide's active metabolite A77 1726.
    Schorlemmer HU; Kurrle R; Schleyerbach R; Bartlett RR
    Inflamm Res; 1999 Dec; 48 Suppl 2():S111-2. PubMed ID: 10667839
    [No Abstract]   [Full Text] [Related]  

  • 20. The immunosuppressant leflunomide inhibits lymphocyte proliferation by inhibiting pyrimidine biosynthesis.
    Cherwinski HM; Cohn RG; Cheung P; Webster DJ; Xu YZ; Caulfield JP; Young JM; Nakano G; Ransom JT
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1043-9. PubMed ID: 7473131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.